The pharmaceutical business has changed significantly in recent years.
Only a few years ago, marketing and medical were (and had to be) strictly separated. Today boundaries are becoming increasingly seamless.
Terms such as "personalized medicine" and "biomarkers" are increasingly finding their place and also signaling a new approach to therapies.
Political conditions such as the AMNOG procedure require new perspectives when preparing pivotal trials and thus change the classic model of medical affairs departments.
We support your medical projects with scientific understanding, operational know-how and innovative approaches.